IP Library Granted Patent US 10,307,279
Granted Patent B2
US 10,307,279 · App. 15/818,482 · Granted Jun 4, 2019

Ingestible delivery systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,307,279
App. No.
15/818,482
Granted
Jun 4, 2019
Kind
B2
Abstract

Methods, devices and systems for delivering a device assembly using a shaped body allowing for ease of ingestion of a gastric device into a gastric space, allowing the gastric device to expand to occupy volume within the gastric space and, after an effective period of time release from the body.

Claims (28)

1. An ingestible delivery system for ingestion of an object by a patient, the delivery system comprising:

a dosage shape having the object embedded therein to facilitate delivery of the object into the gastric space of the patient, where the dosage shape extends away from the object with bi-lateral symmetry to prevent the patient from sensing the object during ingestion, the dosage shape having a length along a first axis between a proximal end and a distal end, where the length is greater than a width of the dosage shape, a first surface and a second surface disposed on opposing sides of a plane of bi-lateral symmetry, a thickness between the first surface and the second surface, the first and second surfaces being smoothly continuous between the proximal end and distal end;

a bulge region on the first surface of the dosage shape, where the bulge region comprises a maximum thickness of the dosage shape;

a proximal tapering surface on the first surface that tapers from the bulge region to the proximal end such that a proximal thickness of the dosage shape decreases along the first axis towards the proximal end;

a distal tapering surface on the first surface that tapers from the bulge region to the distal end, such that a distal thickness of the dosage shape decreases along the first axis where a length of the proximal tapering surface is less than a length of the distal tapering surface; and

where the dosage shape comprises a degradable material that is degradable in the gastric space allowing for release of the object subsequent to ingestion.

2. The ingestible delivery system of claim 1 , where the second surface is shallowly elliptically convex.

3. The ingestible delivery system of claim 2 , where the shallowly elliptically convex second surface comprises a trough that is parallel to the first axis and that extends from the proximal end to the distal end.

4. The ingestible delivery system of claim 1 , where the distal end is bulbous.

5. The ingestible delivery system of claim 1 , where the proximal end comprises a flat surface to permit a tongue of the patient to push the dosage shape.

6. The ingestible delivery system of claim 1 , further comprising a smooth surface texture.

7. The ingestible delivery system of claim 1 wherein the first surface comprises two laterally symmetric surfaces adapted to match a roof of a mouth of the patient in the vicinity of the junction between the hard and soft palate of the patient.

8. The ingestible delivery system of claim 1 , wherein the dosage shape comprises a lubricious surface.

9. The ingestible delivery system of claim 1 , where the dosage shape comprises a coefficient of friction that decreases when lubricated.

10. The ingestible delivery system of claim 1 , where dosage shape further includes a liquid impermeable material.

11. The ingestible delivery system of claim 1 , where the dosage shape is at least partially elastically deformable in response to pressure.

12. The ingestible delivery system of claim 1 where the object comprises a reduced profile with a volume greater than 1.4 ml.

13. The ingestible delivery system of claim 1 , where a thickness of the degradable material around the object is at least 1 millimeter.

14. The ingestible delivery system of claim 1 , where the width is between 8 and 35 millimeters.

15. An ingestible delivery system for ingestion by a patient, the delivery system comprising:

a dosage shape encasing an object for delivery into the gastric space of the patient, where the dosage shape comprises a top surface that tapers from a bulge region along both a first axis and a second axis to form an arch shape configured to substantially conform to a palatal arch of the patient, where a first region along the top surface distal from the bulge region comprises a length greater than a length of a second region that is proximal relative to the bulge region;

the dosage shape comprising a bottom surface opposite to the top surface and having a shallow convex surface being smoothly continuous and extending along a length of the dosage shape, where the top surface and bottom surface combine to reduce a swallowing resistance by mimicking a large bolus of food as formed by a mouth of the patient just prior to initiating swallowing; and

where the dosage shape comprises a degradable material that is degradable in the gastric space allowing for release of the object subsequent to ingestion, where the degradable material surrounds the object to prevent the patient from sensing the object during ingestion.

16. The ingestible delivery system of claim 15 , where the bottom surface is shallowly elliptically convex.

17. The ingestible delivery system of claim 16 , where the shallowly elliptically convex second surface comprises a trough that is parallel to a center axis of the dosage shape that extends from a proximal end to a distal end.

18. The ingestible delivery system of claim 17 , where the distal end is bulbous.

19. The ingestible delivery system of claim 17 , where the proximal end comprises a flat surface to permit a tongue of the patient to push the dosage shape.

20. The ingestible delivery system of claim 15 , further comprising a smooth surface texture.

Assignments (15)
CORRECTIVE ASSIGNMENT TO CORRECT PATENT NUMBER 10307269 AND REPLACE IT WITH 10307279 PREVIOUSLY RECORDED ON REEL 67424 FRAME 592. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Feb 11, 2025
From: COMPUTE HEALTH CORP.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 070191/0885 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE RECORD AND EXPUNGE PATENT NUMBER 10307269 AND REPLACE IT WITH 10307279 PREVIOUSLY RECORDED ON REEL 67428 FRAME 403. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Recorded Oct 18, 2024
From: ALLURION TECHNOLOGIES, INC.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 070129/0072 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECORD AND EXPUNGE PATENT NUMBER 10307269 AND REPLACE IT WITH 10307279 PREVIOUSLY RECORDED ON REEL 67424 FRAME 616. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded Sep 13, 2024
From: ALLURION TECHNOLOGIES OPCO, INC.; COMPUTE HEALTH LLC
To: ALLURION TECHNOLOGIES, LLC
Reel/Frame 068997/0947 →
CORRECTIVE ASSIGNMENT TO CORRECT THE WRONG PATENT NUMBER 10307269 TO PATENT NUMBER 10307279 PREVIOUSLY RECORDED AT REEL: 67424 FRAME: 403. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Sep 13, 2024
From: COMPUTE HEALTH CORP.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 068935/0273 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER FROM 10307269 TO 10307279 PREVIOUSLY RECORDED ON REEL 67135 FRAME 251. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jun 25, 2024
From: ALLURION TECHNOLOGIES, LLC
To: RTW INVESTMENTS, LP
Reel/Frame 067838/0268 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER FROM 10307269 TO 10307279 PREVIOUSLY RECORDED ON REEL 67135 FRAME 677. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Jun 25, 2024
From: ALLURION TECHNOLOGIES, LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 067962/0692 →
MERGER AND CHANGE OF NAME Recorded May 15, 2024
From: ALLURION TECHNOLOGIES OPCO, INC.; COMPUTE HEALTH LLC
To: ALLURION TECHNOLOGIES, LLC
Reel/Frame 067424/0616 →
MERGER Recorded May 15, 2024
From: COMPUTE HEALTH CORP.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 067424/0592 →
CHANGE OF NAME Recorded May 15, 2024
From: ALLURION TECHNOLOGIES, INC.
To: ALLURION TECHNOLOGIES OPCO, INC.
Reel/Frame 067428/0403 →
SECURITY INTEREST Recorded Apr 17, 2024
From: ALLURION TECHNOLOGIES, LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 067135/0677 →
SECURITY INTEREST Recorded Apr 17, 2024
From: ALLURION TECHNOLOGIES, LLC
To: RTW INVESTMENTS, LP
Reel/Frame 067135/0251 →
SECURITY INTEREST Recorded Aug 22, 2023
From: ALLURION TECHNOLOGIES, LLC
To: RTW INVESTMENTS, LP
Reel/Frame 064662/0956 →
SECURITY INTEREST Recorded Aug 1, 2023
From: ALLURION TECHNOLOGIES, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 064456/0568 →
SECURITY INTEREST Recorded Aug 1, 2023
From: ALLURION TECHNOLOGIES, LLC
To: FORTRESS CREDIT CORP.
Reel/Frame 064453/0271 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2017
From: LEVY, SAMUEL G.; GAUR, SHANTANU K.; WECKER, JONATHAN; HORWITZ, BRUCE A.
To: ALLURION TECHNOLOGIES, INC.
Reel/Frame 044182/0671 →
Cited By (4)
US 12,209,677 US 12,245,962 US 12,246,163 US 12,409,056